InVivo Therapeutics Holdings Price to Book Ratio 2012-2023 | NVIVQ
Historical price to book ratio values for InVivo Therapeutics Holdings (NVIVQ) over the last 10 years. The current price to book ratio for InVivo Therapeutics Holdings as of January 16, 2026 is 0.00.
| InVivo Therapeutics Holdings Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-07-19 | 0.37 | 0.13 | |
| 2023-09-30 | 1.12 | $2.87 | 0.39 |
| 2023-06-30 | 1.35 | $3.73 | 0.36 |
| 2023-03-31 | 1.06 | $4.34 | 0.24 |
| 2022-12-31 | 2.35 | $6.48 | 0.36 |
| 2022-09-30 | 4.29 | $7.26 | 0.59 |
| 2022-06-30 | 4.05 | $9.21 | 0.44 |
| 2022-03-31 | 8.75 | $11.32 | 0.77 |
| 2021-12-31 | 11.50 | $13.21 | 0.87 |
| 2021-09-30 | 17.50 | $15.28 | 1.15 |
| 2021-06-30 | 18.50 | $17.01 | 1.09 |
| 2021-03-31 | 24.75 | $18.62 | 1.33 |
| 2020-12-31 | 20.25 | $20.30 | 1.00 |
| 2020-09-30 | 35.50 | $39.98 | 0.89 |
| 2020-06-30 | 39.50 | $51.36 | 0.77 |
| 2020-03-31 | 42.25 | $92.92 | 0.45 |
| 2019-12-31 | 165.00 | $253.31 | 0.65 |
| 2019-09-30 | 375.00 | $619.61 | 0.61 |
| 2019-06-30 | 555.00 | $843.95 | 0.66 |
| 2019-03-31 | 1162.50 | $1,092.06 | 1.06 |
| 2018-12-31 | 1132.50 | $1,299.27 | 0.87 |
| 2018-09-30 | 1515.00 | $1,631.05 | 0.93 |
| 2018-06-30 | 1275.00 | $-351.44 | -3.63 |
| 2018-03-31 | 10125.00 | $4,000.32 | 2.53 |
| 2017-12-31 | 14437.50 | $7.38 | 1955.88 |
| 2017-09-30 | 27187.50 | $0.42 | 65244.78 |
| 2017-06-30 | 50625.00 | $0.59 | 85790.54 |
| 2017-03-31 | 75937.50 | $0.75 | 101670.24 |
| 2016-12-31 | 78750.00 | $0.90 | 87083.93 |
| 2016-09-30 | 127500.00 | $1.03 | 124244.79 |
| 2016-06-30 | 108375.00 | $1.18 | 91874.36 |
| 2016-03-31 | 130875.00 | $1.30 | 100526.15 |
| 2015-12-31 | 135000.00 | $0.62 | 219512.20 |
| 2015-09-30 | 161625.00 | $0.63 | 255857.21 |
| 2015-06-30 | 302812.00 | $0.59 | 513851.18 |
| 2015-03-31 | 222750.00 | $0.39 | 564209.73 |
| 2014-12-31 | 99000.00 | $0.25 | 391923.99 |
| 2014-09-30 | 42000.00 | $0.15 | 289655.17 |
| 2014-06-30 | 78000.00 | $0.15 | 519307.59 |
| 2014-03-31 | 132000.00 | $0.11 | 1149825.78 |
| 2013-12-31 | 172500.00 | $0.16 | 1053113.55 |
| 2013-09-30 | 107250.00 | $0.22 | 479436.75 |
| 2013-06-30 | 309750.00 | $0.29 | 1085318.85 |
| 2013-03-31 | 179250.00 | $-0.22 | -826798.89 |
| 2012-12-31 | 130500.00 | $-0.04 | -3717948.72 |
| 2012-09-30 | 116250.00 | $0.08 | 1388888.89 |
| 2012-06-30 | 171750.00 | $-0.07 | -2349521.20 |
| 2012-03-31 | 186000.00 | $-0.13 | -1404833.84 |
| 2011-12-31 | 206250.00 | $-0.58 | -355480.87 |
| 2011-09-30 | 49500.00 | $-0.01 | -4342105.26 |
| 2011-06-30 | 74250.00 | $-0.08 | -978260.87 |
| 2011-03-31 | 63750.00 | $-0.06 | -1089743.59 |
| 2010-12-31 | 168750.00 | $-0.04 | -4700557.10 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.000B | $0.000B |
| InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $214.803B | 24.76 |
| EssilorLuxottica (ESLOY) | France | $151.023B | 0.00 |
| Stryker (SYK) | United States | $138.625B | 27.52 |
| Boston Scientific (BSX) | United States | $133.464B | 30.52 |
| Medtronic (MDT) | Ireland | $126.919B | 17.58 |
| Medline (MDLN) | United States | $56.109B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.167B | 0.00 |
| Agilent Technologies (A) | United States | $41.059B | 25.95 |
| ResMed (RMD) | United States | $38.047B | 26.33 |
| GE HealthCare Technologies (GEHC) | United States | $37.585B | 17.98 |
| Koninklijke Philips (PHG) | Netherlands | $29.051B | 18.98 |
| Terumo (TRUMY) | Japan | $20.817B | 23.43 |
| Insulet (PODD) | United States | $20.154B | 62.55 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.589B | 10.97 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.974B | 0.00 |
| Baxter (BAX) | United States | $10.471B | 8.45 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.688B | 31.24 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.338B | 13.22 |
| BillionToOne (BLLN) | United States | $4.335B | 0.00 |
| Envista Holdings (NVST) | United States | $4.060B | 23.29 |
| ICU Medical (ICUI) | United States | $3.829B | 24.31 |
| Haemonetics (HAE) | United States | $3.464B | 15.42 |
| Prestige Consumer Healthcare (PBH) | United States | $3.155B | 14.39 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.403B | 15.45 |
| Perrigo (PRGO) | Ireland | $2.088B | 5.23 |
| AtriCure (ATRC) | United States | $2.061B | 0.00 |
| Neogen (NEOG) | United States | $2.058B | 45.05 |
| LeMaitre Vascular (LMAT) | United States | $1.962B | 39.50 |
| Curaleaf Holdings (CURLF) | Canada | $1.846B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.715B | 75.18 |
| Phibro Animal Health (PAHC) | United States | $1.624B | 16.22 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.459B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.441B | 20.86 |
| Kestra Medical Technologies (KMTS) | United States | $1.341B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.178B | 349.57 |
| Capricor Therapeutics (CAPR) | United States | $1.099B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.090B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.944B | 0.00 |
| InMode (INMD) | Israel | $0.888B | 10.04 |
| Omeros (OMER) | United States | $0.866B | 0.00 |
| Valneva SE (VALN) | France | $0.865B | 0.00 |
| CeriBell (CBLL) | United States | $0.847B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.581B | 15.75 |
| Cerus (CERS) | United States | $0.526B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.494B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.486B | 0.00 |
| Brainsway (BWAY) | Israel | $0.452B | 77.00 |
| Canopy Growth (CGC) | Canada | $0.450B | 0.00 |
| SNDL (SNDL) | Canada | $0.426B | 0.00 |
| Quanterix (QTRX) | United States | $0.371B | 0.00 |
| Evolus (EOLS) | United States | $0.324B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.307B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.287B | 22.85 |
| TerrAscend (TSNDF) | Canada | $0.244B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.33 |
| Sanuwave Health (SNWV) | United States | $0.238B | 0.00 |
| High Tide (HITI) | Canada | $0.220B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.215B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.212B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| Accendra Health (ACH) | United States | $0.196B | 1.96 |
| Utah Medical Products (UTMD) | United States | $0.193B | 17.02 |
| Vireo Growth (VREOF) | United States | $0.193B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| Apyx Medical (APYX) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.147B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.147B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.117B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.79 |
| Exagen (XGN) | United States | $0.109B | 0.00 |
| Biote (BTMD) | United States | $0.109B | 4.78 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Sharps Technology (STSS) | United States | $0.067B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.54 |
| Nephros (NEPH) | United States | $0.047B | 33.69 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.86 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Jin Medical (ZJYL) | China | $0.023B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |